Page Image

Nephrology Times

Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.

AKI
FDA Approves Lupin’s Generic Tolvaptan Tablets
Lupin's generic tolvaptan tablets are now FDA-approved for treating autosomal dominant polycystic kidney disease (ADPKD).
Advertisement

Latest News

Expert Interviews

In Print

Conferences

Podcasts

Expert Columns

Knowledge Hubs

Acute Kidney Injury
Advertisement
Advertisement
Nephrology Times Chair

Editorial Board